🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.70
-1.90 (-2.62%)
Nov 20, 2026, 1:30 PM CST

A Plus Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
380.09604.35360.97319.07237.69305.09
Short-Term Investments
103430---
Cash & Short-Term Investments
483.09608.35390.97319.07237.69305.09
Cash Growth
-18.52%55.60%22.54%34.24%-22.09%5.45%
Accounts Receivable
202.04178.33184.53141.67146.64133.31
Other Receivables
-0.18-2.113.073.07
Receivables
202.04178.5184.53143.77149.71136.38
Inventory
391.38354.54286.94283.76295.69300.67
Prepaid Expenses
42.4539.3729.2617.4924.0816.06
Other Current Assets
2.156.35.155.496.463.07
Total Current Assets
1,1211,187896.85769.58713.63761.27
Property, Plant & Equipment
364.18243.75251.91259.02259.63233.38
Long-Term Investments
86.2387.66----
Goodwill
----164.46164.46
Other Intangible Assets
6.053.976.518.2411.7413.7
Long-Term Deferred Tax Assets
18.1413.9912.6631.2412.79.8
Other Long-Term Assets
26.9613.589.383.2612.3523.24
Total Assets
1,6231,5501,1771,0711,1751,206

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
58.2841.0639.428.942.2342.68
Accrued Expenses
-70.1172.4843.6949.3856.4
Short-Term Debt
-----37.8
Current Portion of Long-Term Debt
-4.824.724.787.837.37
Current Portion of Leases
2.298.278.078.648.969.78
Current Income Taxes Payable
17.6732.932.9519.5620.387.97
Current Unearned Revenue
2.922.960.911.496.830.9
Other Current Liabilities
119.9637.9834.7735.7738.0340.44
Total Current Liabilities
201.12198.13163.31142.83173.63203.35
Long-Term Debt
153.7482.3887.293.83116.44153.98
Long-Term Leases
0.590.626.825.795.673.31
Long-Term Deferred Tax Liabilities
6.512.990.01-0.050.11
Other Long-Term Liabilities
0.260.320.940.930.921.16
Total Liabilities
362.21284.45258.27243.38296.71361.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
345.71345.71304.71304.71304.71304.71
Additional Paid-In Capital
549.43--360.01-360.01
Retained Earnings
386.37347.55300.05177.04209.47179
Treasury Stock
-43.94-38.66--14.15--
Comprehensive Income & Other
19.67608.19314.290.35363.630.22
Total Common Equity
1,2571,263919.05827.94877.81843.94
Minority Interest
3.222.77----
Shareholders' Equity
1,2601,266919.05827.94877.81843.94
Total Liabilities & Equity
1,6231,5501,1771,0711,1751,206

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
156.6296.1106.81113.03138.9212.24
Net Cash (Debt)
326.48512.26284.16206.0398.7992.85
Net Cash Growth
-33.84%80.27%37.92%108.55%6.40%-62.95%
Net Cash Per Share
9.5215.579.366.813.233.22
Filing Date Shares Outstanding
33.9833.730.4729.930.4730.47
Total Common Shares Outstanding
33.9833.730.4730.1830.4730.47
Working Capital
920988.93733.54626.75540557.92
Book Value Per Share
36.9937.4830.1627.4328.8127.70
Tangible Book Value
1,2511,259912.54819.7701.6665.77
Tangible Book Value Per Share
36.8237.3629.9527.1623.0321.85
Land
-117.34117.34117.34117.34117.34
Buildings
-116.27115.92103.55103.2188.96
Machinery
-34.7735.1546.8469.6558.17
Construction In Progress
-0.10.2113.488.71-
Leasehold Improvements
-12.795.195.626.597.81